National expert consensus on short-acting beta <sub>2</sub> -agonist overreliance in asthma care in Malaysia-Reference-Cited by-同舟云学术

National expert consensus on short-acting beta ₂ -agonist overreliance in asthma care in Malaysia

Published:2024-07 Issue: Volume: Page:1-13
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Ban Andrea Yu-Lin¹,Taher Sri Wahyu²,Muneswarao Jaya³,Ho Bee Kiau⁴,Ahmad Rashidi⁵,Pereirasamy Lalitha⁶,Chong Li Yin⁷,Md Jamal Shamsuriani⁸,Alaga Arvindran⁹,Haja Mydin Helmy¹⁰,Chang Li Cheng¹¹,Md Isa Nor Azila¹²,Mohd Zim Mohd Arif¹³

Affiliation:

1. Department of Medicine, Hospital Canselor Tuanku Muhriz, Cheras, Kuala Lumpur, Malaysia

2. Department of Family Medicine, Klinik Kesihatan Simpang Kuala, Alor Setar, Kedah, Malaysia

3. Department of Pharmacy, Hospital Pulau Pinang, Penang, Malaysia

4. Department of Family Medicine, Klinik Kesihatan Bandar Botanik, Klang, Selangor, Malaysia

5. Department of Emergency Medicine, KPJ Seremban Specialist Hospital, Negeri, Sembilan, Malaysia

6. Department of Respiratory Medicine, Hospital Pulau Pinang, Penang, Malaysia

7. Department of Pharmacy, Hospital Sultan Idris Shah Serdang, Kajang, Selangor, Malaysia

8. Department of Emergency, Hospital Canselor Tuanku Muhriz, Cheras, Kuala Lumpur, Malaysia

9. Department of Family Medicine, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia

10. Department of Lung Centre, Hospital Pantai, Kuala Lumpur, Malaysia

11. Department of Family Medicine, Klinik Kesihatan Kuang, Rawang, Selangor, Malaysia

12. Department of Family Medicine, Klinik Kesihatan Nilai, Seremban, Negeri Sembilan, Malaysia

13. Department of Respiratory Medicine, Damansara Specialist Hospital 2, Bukit Lanjan, Kuala Lumpur, Malaysia

Funder

AstraZeneca Malaysia

Mediconnexions Consulting Sdn. Bhd

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2024.2361780

Reference81 articles.

1. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

2. The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan

3. The impact of inappropriate use of short acting beta agonists in asthma

4. Global Initiative for Asthma - GINA. Global strategy for asthma management and prevention (2019 update) [assessed 15 May 2024]. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf.

5. Short-acting β2-agonist prescription patterns and clinical outcomes in Malaysia: A nationwide cohort of the SABINA III study